# A Study of Danning Tablet in Patients With Polypoid Lesions of Gallbladder

> **NCT05668871** · PHASE4 · UNKNOWN · sponsor: **Eastern Hepatobiliary Surgery Hospital** · enrollment: 336 (estimated)

## Conditions studied

- Polyps Gallbladder

## Interventions

- **DRUG:** Danning Tablet

## Key facts

- **NCT ID:** NCT05668871
- **Lead sponsor:** Eastern Hepatobiliary Surgery Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-01
- **Primary completion:** 2024-08-31
- **Final completion:** 2024-11-30
- **Target enrollment:** 336 (ESTIMATED)
- **Last updated:** 2022-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05668871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05668871, "A Study of Danning Tablet in Patients With Polypoid Lesions of Gallbladder". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05668871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*